Analysis of the vascular patterns of 52 amelanotic cutaneous melanoma metastases: a prospective descriptive study

  • Danijela Popović University Clinical Center Niš, Clinic for Dermatovenereology, Niš, Serbia
  • Željko Mijušković Military Medical Academy, Department for Dermatology and Venereology, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Andrija Jović University Clinical Center Niš, Clinic for Dermatovenereology, , Niš, Serbia
  • Sladjana Cekić University Clinical Center Niš, Clinic for Dermatovenereology, , Niš, Serbia
  • Nataša Vidović University Clinical Center Niš, Center for Pathology and Pathological Anatomy, Niš, Serbia
  • Danica Tiodorović University Clinical Center Niš, Niš, Serbia; University of Niš, Faculty of Medicine, Niš, Serbia
Keywords: blood vessels;, dermoscopy;, diagnosis;, melanoma, amelanotic;, neoplasm metastasis;, skin.

Abstract


Background/Aim. Early diagnosis of amelanotic cutaneous melanoma metastases (ACMM) represents a great challenge and is essential for determining the stage, treatment, and prognosis of the disease. The aim of the study was to evaluate the vascular structures and their arrangement and frequency in ACMM. Methods. The study was conducted as a prospective, descriptive, multicenter study of pathohistologically confirmed ACMM. Results. The study included a total of 52 ACMM from 17 patients (8 men and 9 women, with an age range of 32–91 years, median 63.12 years) with a previous history of primary melanoma. The most prevalent were elevated ACMM – 39 (75.0%) lesions, while 13 (25.0%) ACMM were flat. Linear irregular blood vessels were statistically significantly more often associated with elevated ACMM, compared to flat ACMM (92.3% vs. 50.0%, p < 0.001). Dotted blood vessels were statistically significantly more frequent in flat ACMM, compared to elevated ACMM (76.9% vs. 28.2%, p = 0.003). Diffuse distribution of blood vessels was the most prevalent, with 92.3% of flat ACMM and 76.9% of elevated ACMM (p = 0.416). Peripheral arrangement of blood vessels was detected in 15.4% of elevated ACMM and 7.7% of flat ACMM (p = 0.815). The central arrangement of blood vessels was seen in 2.6%, while the cluster (segmental) schedule was present in 5.1% of elevated ACMM. The monomorphic vascular pattern was the predominant pattern in 84.6% of flat ACMM and 61.5% of elevated ACMM (p = 0.232). Conclusion. Our study supports the finding that linear irregular blood vessels are more commonly associated with elevated ACMM, while the dotted ones are dominant in flat ACMM.

References

Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol 2010; 63(3): 361–74; quiz 375–6.

Plaza JA, Torres-Cabala C, Evans H, Diwan H A, Suster S, Prieto VG. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol 2010; 32(2): 129–36.

Abernethy JL, Soyer HP, Kerl H, White WL. Epidermotropic metastatic malignant melanoma simulating melanoma in situ. A report of 10 examples from two patients. Am J Surg Pathol 1994; 18(11): 1140–9.

Heenan PJ, Clay CD. Epidermotropic metastatic melanoma simulating multiple primary melanomas. Am J Dermatopathol 1991; 13(4): 396–402.

Bono R, Giampetruzzi AR, Concolino F, Puddu P, Scoppola A, Sera F, et al. Dermoscopic patterns of cutaneous melanoma metastases. Melanoma Research 2004; 14(5): 367–73.

Chernoff KA, Marghoob AA, Lacouture MA, Deng L, Busam KJ, Myskowski PL. Dermoscopic Findings in Cutaneous Metastases. JAMA Dermatol 2014; 150(4): 429–33.

Koch SE, Lange JR. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol 2000; 42(5 Pt 1): 731–4.

R Development Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing, Vienna, Austria; 2014 [accessed on: 2024 Aug 13]. Available from: http://www.R-project.org/

Pizzichetta MA, Canzonieri V, Massarut S, Baresic T, Borsatti E, Menzies SW. Pitfalls in the dermoscopic diagnosis of amelanotic melanoma. J Am Acad Dermatol 2010; 62(5): 893–4.

Jaimes N, Halpern JA, Puig S, Malvehy J, Myskowski PL, Braun RP, Marghoob AA. Dermoscopy: an aid to the detection of amelanotic cutaneous melanoma metastases. Dermatol Surg 2012; 38(9): 1437–44.

Mendes MS, Costa MC, Gomes CM, de Araújo LC, Takano GH. Amelanotic metastatic cutaneous melanoma. An Bras Dermatol 2013; 88(6): 989–91.

Kuonen F, Gaide O. Residents’ corner February 2015. Clues in Dermoscopy: Dermoscopy of amelanotic cutaneous melanoma metastases. Eur J Dermatol 2015; 25(1): 97–8.

Kostaki M, Plaka M, Moustaki M, Befon A, Champsas G, Kypreou K, et al. Cutaneous melanoma metastases: Clinical and dermoscopic findings. J Eur Acad Dermatol Venereol 2023; 37(5): 941–4.

Tiodorovic D, Stojkovic-Filipovic J, Marghoob A, Argenziano G, Puig S, Malvehy J, et al. Dermatoscopic patterns of cutaneous metastases: A multicentre cross-sectional study of the International Dermoscopy Society. J Eur Acad Dermatol Venereol 2024; 38(7): 1432–8.

Savoia P, Fava P, Nardò T, Osella-Abate S, Quaglino P, Bernengo MG. Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res 2009; 19(5): 321–6.

Reed KB, Cook-Norris RH, Brewer JD. The cutaneous manifestation of metastatic malignant melanoma. Internat J Dermatol 2012; 51(3): 243–9.

Zalaudek I, Argenziano G, Kerl H, Soyer HP, Hofmann-Wellenhof R. Amelanotic/Hypomelanotic melanoma--Is dermatoscopy useful for diagnosis? J Dtsch Dermatol Ges 2003; 1(5): 369–73.

Al-Ostoot FH, Salma Salah S, Khamees HA, Khanum SA. Tumor angiogenesis: Current challenges and therapeutic opportunities. Cancer Treat Res Commun 2021; 28: 100422.

Rubegni P, Lamberti A, Mandato F, Perotti R, Fimiani M. Dermoscopic patterns of cutaneous melanoma metastases. Int J Dermatol 2014; 53(4): 404–12.

Martín JM, Bella-Navarro R, Jordá E. Vascular patterns in dermoscopy. Actas Dermosifiliogr 2012; 103(5): 357–75. (Spanish)

Moloney FJ, Menzies SW. Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma. J Dermatol 2011; 38; 10–5.

Stojkovic-Filipovic J, Kittler H. Dermatoscopy of amelanotic and hypomelanotic melanoma. J Dtsch Dermatol Ges 2014; 12(6): 467–72.

Leiter U, Buettner PG, Eigentler TK, Forschner A, Meier F, Garbe C. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res 2010; 20(3): 240–6.

Niebling MG, Haydu LE, Lo SN, Rawson RV, Lamboo LGE, Stollman JT, et al. The prognostic significance of microsatellites in cutaneous melanoma. Mod Pathol 2020; 33(7): 1369–79.

Mrazek AA, Chao C. Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence. Surg Clin North Am 2014; 94(5): 989–1002; vii–viii.

Published
2024/11/29
Section
Original Paper